Exhibit 99.1

Eclipsys Releases Financial Results for

Quarter Ended September 30, 2007

- Company Announces Decision to Exit Networking Services Business -

Atlanta, GA —November 1, 2007 — Eclipsys Corporation^® (NASDAQ: ECLP), The Outcomes Company^®, today released results for the quarter ended September 30, 2007.

Third-Quarter Results

Revenues for the quarter ended September 30, 2007, increased by 11.5 percent to $121.1 million, compared with revenues of $108.6 million for the quarter ended September 30, 2006. On a GAAP basis, the net income for the third-quarter of 2007 was $8.9 million, or $0.17 per share on a basic basis and $0.16 per share on a diluted basis, compared to net income of $5.6 million, or $0.11 per share on a basic and diluted basis in the third-quarter of 2006. This represents a $3.3 million or 58.9 percent increase in net income.

Net income for the third-quarter of 2007 included stock-based compensation expense of $2.7 million, as well as derivative litigation expenses related to the company’s voluntary stock option review which aggregated $200,000. Excluding these charges, the company’s non-GAAP net income was $11.8 million, or $0.22 per share on a basic and diluted basis. Net income for the third-quarter of 2006 included stock-based compensation expense of $2.7 million. Excluding this charge, the company’s third-quarter 2006 non-GAAP net income was $8.3 million, or $0.16 per share on a basic and diluted basis.

The company’s operating cash flows for the third-quarter of 2007 were $22.4 million, an increase of $12.2 million compared to the third quarter of 2006, and the company ended the quarter with $149.5 million in cash and marketable securities.

The following table summarizes (unaudited) select financial data:

1750 Clint Moore Road, Boca Raton, FL 33487 • phone 561.322.4321 • fax 561.322.4320 • info@eclipsys.com

Eclipsys Releases Financial Results for Quarter Ended September 30, 2007

November 1, 2007

Page 2 of 4

	In thousands, except per share data

	Three months ended September 30,									Nine months ended September 30,
	2007		2006		$ Change		% Change			2007		2006			$ Change		% Change
Revenues	$	121,080	$	108,566	$	12,514		11.5	%	$	353,129	$	311,854		$	41,275		13.2	%
Net income (loss)		8,864		5,577		3,287		58.9	%		16,959		(575	)		17,534		n/a
Earnings (loss) per common share, basic	$	0.17	$	0.11	$	0.06		54.5	%	$	0.32		($0.01	)	$	0.33		n/a
Earnings (loss) per common share, diluted	$	0.16	$	0.11	$	0.05		45.5	%	$	0.31		($0.01	)	$	0.32		n/a


	Non-GAAP Results*									Non-GAAP Results*
	Three months ended September 30,									Nine months ended September 30,
	2007		2006		$ Change		% Change			2007		2006		$ Change		% Change
Revenues	$	121,080	$	108,566	$	12,514		11.5	%	$	353,129	$	311,854	$	41,275		13.2	%
Net income*		11,751		8,298		3,453		41.6	%		27,550		16,200		11,350		70.1	%
Earnings per common share, basic*	$	0.22	$	0.16	$	0.06		37.5	%	$	0.52	$	0.32	$	0.20		62.5	%
Earnings per common share, diluted*	$	0.22	$	0.16	$	0.06		37.5	%	$	0.51	$	0.32	$	0.19		59.4	%

*A reconciliation of GAAP to non-GAAP results is included in the attached table.

“Eclipsys continues to see positive results from the organizational changes we’ve introduced over the last 24 months. We are operating at a much higher level as a business, which is evidenced by increased cash flow, improved margins, and growth in EPS,” said R. Andrew Eckert, Eclipsys president and chief executive officer. “We continue to make progress by activating more clients on our ambulatory solutions, helping clients achieve outcome improvements and winning new clients such as Bronx-Lebanon Hospital Center Health System. Another significant accomplishment this quarter was the signing of SingHealth, as it gives us an anchor client to help grow our international business.”

Continued Eckert, “We exited our low-margin networking services business, which reflects our ongoing efforts to focus on core, higher-margin elements of our business. We also announced the move of our corporate headquarters to Atlanta, Georgia. By consolidating more of our operations in Atlanta, Eclipsys will be able to reduce overheard costs and better leverage our existing investment there, including our new Outcomes Strategy Center.”

Added Eckert, “In October, we held our annual Eclipsys User Network (EUN), where we had record attendance. We believe this year’s EUN will add to our business momentum.”

Guidance

The company expects 2007 annual revenues to range from $473 million to $476 million, slightly down from earlier guidance, due mainly to the company’s decision to exit the networking services business. 2007 EPS on a GAAP basis is expected to range from $0.47 to $0.51. Excluding stock-based compensation expenses, costs related to the company’s voluntary stock option review and related derivative litigation, and costs associated with the relocation of the company’s corporate headquarters, non-GAAP 2007 EPS is expected to range from $0.77 to $0.81.

Eclipsys Releases Financial Results for Quarter Ended September 30, 2007

November 1, 2007

Page 3 of 4

Investor Teleconference November 1

Eclipsys senior executives will discuss the results on a teleconference for investors scheduled for 8:30 a.m. Eastern time on November 1, 2007. Persons interested in participating in the teleconference should call (800) 398-9367 around 15 minutes before the conference is slated to begin. For listen-only mode, participants can go to www.eclipsys.com prior to the conference call to register and download the necessary audio software. An audio replay will be available at www.eclipsys.com approximately 2 hours after the completion of the call on November 1.

Non-GAAP Measures

The financial results reported in this press release have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). In addition to the GAAP results, the company has provided net income and earnings per share information on a non-GAAP basis: (i) for the three and nine month periods ended September 30, 2007 to exclude stock-based compensation expenses and costs related to the company’s voluntary stock option review and related derivative litigation; (ii) for the three month period ended September 30, 2006 to exclude stock-based compensation expenses; and (iii) for the nine month period ended September 30, 2006 to exclude stock-based compensation expenses and restructuring charges. These non-GAAP financial measures should not be considered a substitute for, or superior to, any measure derived in accordance with GAAP. These non-GAAP financial measures may also be inconsistent with the manner in which similar measures are derived or used by other companies. Internally, management uses this non-GAAP information for forecasting and to help make management decisions, as an indicator of business performance, and to evaluate management’s effectiveness and help determine bonuses for management and others. The economic substance of omitting non-cash stock-based compensation expense in presenting non-GAAP earnings derives from providing investors with consistent measures of performance both before and after including non-cash stock-based compensation charges. The economic substance of omitting the expenses related to the company’s voluntary stock option review and related derivative litigation and restructuring charges in presenting non-GAAP earnings derives from the fact that episodic charges of this kind make it more difficult to compare operating results of different periods, not all of which include such expenses and charges. The omission of non-cash stock-based compensation expense may mask an economic cost incurred by the company in connection with stock-based compensation, and the omission of the expenses related to the company’s voluntary stock option review and related derivative litigation and restructuring charges may mask actual and expected future cash expenditures associated with such matters. Management compensates for these limitations by using both the GAAP and non-GAAP measures. Management believes that the non-GAAP financial measures provided, when considered in conjunction with comparable GAAP financial measures, facilitate the understanding and evaluation of the company’s operating performance and future prospects, as well as comparisons of the company’s results with its prior period results that did not include these charges and with results of other companies on a more consistent basis. Omitting the stock-based compensation expense facilitates review by the majority of the company’s analysts, who model the company’s earnings excluding stock-based compensation charges. Omitting the 2007 expenses related to the company’s voluntary stock option review and related derivative litigation facilitates comparison between the 2006 and 2007 nine month periods, as no voluntary stock option review and related derivative litigation were recorded in the 2006 period. Omitting the 2006 restructuring charges facilitates comparison between the 2006 and 2007 nine month periods, as no restructuring charges were recorded in the 2007 period. The company has provided reconciling information in the attachment to this release.

Condensed Consolidated Statement of Cash Flows

The attached Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2006 has been restated in connection with the company’s restatement of its prior financial statements. For additional information regarding this prior restatement, please refer to Exhibit 99.1 in our Annual Report on Form 10-K for the year ended December 31, 2006, filed on May 23, 2007.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and access management software, clinical content and professional services that help healthcare organizations improve clinical, financial, operational and client satisfaction outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.

Eclipsys Releases Financial Results for Quarter Ended September 30, 2007

November 1, 2007

Page 4 of 4

Special Note

Statements in this news release or the investor call referenced herein concerning the company’s sales, marketing and operational initiatives; future financial results, operating performance, and development efforts; and the benefits provided by Eclipsys software and services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Future performance expectations are predicated upon achievement of various sales and performance targets that may be difficult to meet. Sales may be slower than expected due to market conditions, competition, and other factors. Costs may be greater than anticipated due to the potential need to increase spending to ensure performance in accordance with commitments to clients and other factors. Software development may take longer and cost more than expected, and incorporation of anticipated features and functionality may be delayed, due to various factors including programming and integration challenges and resource constraints. The market is highly competitive. Implementation and customization of Eclipsys software is complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from software, implementation or consulting services. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and clients can terminate contracts, assess penalties or reduce contract scope under certain circumstances. More information about company risks is available in recent Form 10-K and other filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Eclipsys

Jason Cigarran

Director of Investor and Media Relations

(561) 322-4355

jason.cigarran@eclipsys.com

Robert J. Colletti

Chief Financial Officer

(561) 322-4655

investor.relations@eclipsys.com

ECLIPSYS CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except per share amounts)

	Three Months Ended				Nine Months Ended
	Sept 30,				Sept 30,
	2007		2006		2007		2006

Revenues:
Systems and services	$	117,530	$	104,266	$	340,979	$	298,417
Hardware		3,550		4,300		12,150		13,437
Total revenues		121,080		108,566		353,129		311,854
-								-
Costs and expenses:								-
Cost of systems and services		65,671		60,938		197,372		175,532
Cost of hardware		2,685		3,489		9,449		10,991
Sales and marketing		17,980		16,208		54,152		46,949
Research and development		14,182		13,094		42,389		44,076
General and administrative		8,339		6,753		23,942		18,593
Depreciation and amortization		4,710		3,885		13,281		11,581
Restructuring charge		-		-		-		8,547
Total costs and expenses		113,567		104,367		340,585		316,269
-								-
Income (loss) from operations before interest and taxes		7,513		4,199		12,544		(4,415	)
Interest income, net		1,814		1,378		4,916		3,840

Income (loss) before taxes		9,327		5,577		17,460		(575	)
Provision for income taxes		463		-		501		-
Net income (loss)	$	8,864	$	5,577	$	16,959	$	(575	)

Income (loss) per common share:
Basic income (loss) per common share	$	0.17	$	0.11	$	0.32	$	(0.01	)
Diluted income (loss) per common share	$	0.16	$	0.11	$	0.31	$	(0.01	)


Weighted average shares outstanding:
Basic		53,100		51,712		52,594		51,312
Diluted		54,380		52,767		53,843		51,312

ECLIPSYS CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands)

	September 30,		December 31,
	2007		2006
Assets
Current assets:
Cash	$	24,512	$	41,264
Marketable securities		124,975		89,549
Accounts receivable, net of allowance for doubtful accounts of $3,945 and $3,907, respectively		99,148		93,821
Inventory		226		1,076
Prepaid expenses		29,529		22,947
Other current assets		955		1,026
Total current assets		279,345		249,683

Property and equipment, net		46,489		45,806
Capitalized software development costs, net		35,741		32,302
Acquired technology, net		732		1,224
Intangible assets, net		2,473		3,307
Deferred tax asset		3,751		3,661
Goodwill		15,012		12,281
Other assets		14,875		15,014
Total assets	$	398,418	$	363,278

Liabilities and Stockholders’ Equity
Current liabilities:
Deferred revenue	$	98,852	$	103,298
Accounts payable		13,025		19,444
Accrued compensation costs		22,035		12,997
Deferred tax liability		3,847		3,699
Other current liabilities		18,831		20,648
Total current liabilities		156,590		160,086

Deferred revenue		10,194		11,289
Other long-term liabilities		2,482		1,247
Total liabilities		169,266		172,622

Stockholders’ equity:
Total stockholders’ equity		229,152		190,656
Total liabilities and stockholders’ equity	$	398,418	$	363,278

ECLIPSYS CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)

	Nine Months Ended September 30,
	2007			2006
				As restated
Operating activities:
Net income (loss)	$	16,959		$	(575	)
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Depreciation and amortization		27,390			27,856
Provision for bad debt		1,378			1,568
Stock compensation expense		8,261			9,390
Gain on sale of investments		16			-
Deferred provision for income taxes		329			-
Changes in operating assets and liabilities:
Increase in accounts receivable		(5,008	)		(4,147	)
Increase in prepaid expenses and other current assets		(6,197	)		(4,927	)
Decrease in inventory		849			479
Decrease in other assets		337			1,592
Decrease in deferred revenue		(6,287	)		(11,235	)
Increase in accrued compensation		9,663			364
Decrease in accounts payable and other current liabilities		(9,658	)		(10,482	)
Increase (decrease) in other long-term liabilities		1,076			(1,108	)
Total adjustments		22,149			9,350
Net cash provided by operating activities		39,108			8,775
Investing activities:
Purchases of property and equipment		(13,065	)		(10,174	)
Purchase of marketable securities		(79,704	)		(72,452	)
Proceeds from sales of marketable securities		44,273			20,950
Capitalized software development costs		(15,278	)		(9,429	)
Change in restricted cash balance		(1,969	)		-
Cash paid for acquisitions		(1,153	)		(4,002	)
Net cash used in investing activities		(66,896	)		(75,107	)
Financing activities:
Proceeds from stock options exercised		10,333			23,181
Proceeds from issuance of common stock in employee stock purchase plan		-			732
Net cash provided by financing activities		10,333			23,913

Effect of exchange rates on cash and cash equivalents		703			4
Net decrease in cash and cash equivalents		(16,752	)		(42,415	)
Cash and cash equivalents — beginning of period		41,264			76,693
Cash and cash equivalents — end of period	$	24,512		$	34,278

ECLIPSYS CORPORATION AND SUBSIDIARIES
Reconciliation of GAAP to Non-GAAP Pro Forma Results
(in thousands, except per share amounts)

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2007		2006		2007		2006

GAAP net earnings (loss)	$	8,864	$	5,577	$	16,959	$	(575	)

Add back:
Share-based compensation expense¹		2,714		2,721		8,261		8,228
Restructuring charge²		-		-		-		8,547
Stock option review³		173		-		2,330		-

Non-GAAP net income	$	11,751	$	8,298	$	27,550	$	16,200


GAAP basic earnings (loss) per share	$	0.17	$	0.11	$	0.32	$	(0.01	)

Add back:
Share-based compensation expense¹		0.05		0.05		0.16		0.16
Restructuring charge²		-		-		-		0.17
Stock option review³		-		-		0.04		-

Non-GAAP basic earnings per share	$	0.22	$	0.16	$	0.52	$	0.32

GAAP diluted earnings (loss) per share	$	0.16	$	0.11	$	0.31	$	(0.01	)

Add back:
Share-based compensation expense¹		0.05		0.05		0.15		0.16
Restructuring charge²		-		-		-		0.17
Stock option review³		-		-		0.04		-

Non-GAAP diluted earnings per share	$	0.22	$	0.16	$	0.51	$	0.32


(1) Relates to share- based compensation expense and is allocated as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2007		2006		2007		2006

Cost of systems & services	$	1,158	$	714	$	3,333	$	2,383
Sales and marketing		698		860		2,378		2,548
Research and development		500		498		1,602		1,349
General and administrative		358		649		948		1,948
Total stock-based compensation expense	$	2,714	$	2,721	$	8,261	$	8,228

(2) This charge is associated with severance costs related to employment terminations that occurred in the first and second quarters of 2006.

(3) This charge was incurred as a result of the voluntary stock option review completed in the second quarter of 2007 and primarily relates to legal and accounting fees, plus subsequent derivative litigation expenses related to such review.